Baker Bros. Advisors as of Sept. 30, 2014
Portfolio Holdings for Baker Bros. Advisors
Baker Bros. Advisors holds 107 positions in its portfolio as reported in the September 2014 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Pharmacyclics | 14.3 | $1.1B | 9.7M | 117.43 | |
Seattle Genetics | 10.5 | $836M | 23M | 37.18 | |
Salix Pharmaceuticals Inc note 2.750% 5/1 | 9.3 | $737M | 219M | 3.36 | |
Synageva Biopharma | 9.2 | $733M | 11M | 68.78 | |
Incyte Corporation (INCY) | 9.2 | $728M | 15M | 49.05 | |
ACADIA Pharmaceuticals (ACAD) | 6.4 | $507M | 21M | 24.76 | |
Genomic Health | 4.9 | $387M | 14M | 28.31 | |
AVANIR Pharmaceuticals | 4.5 | $362M | 30M | 11.92 | |
Incyte Corp Ltd conv | 4.2 | $335M | 275M | 1.22 | |
Incyte Corp Incy Cvt 144a 0.37 convert | 3.9 | $308M | 259M | 1.19 | |
Incyte Corp note 4.750%10/0 | 2.8 | $225M | 40M | 5.57 | |
BioMarin Pharmaceutical (BMRN) | 2.1 | $171M | 2.4M | 72.16 | |
BioCryst Pharmaceuticals (BCRX) | 1.3 | $105M | 11M | 9.78 | |
Anacor Pharmaceuticals In | 1.3 | $103M | 4.2M | 24.47 | |
Gilead Sciences conv | 1.3 | $100M | 22M | 4.67 | |
XOMA CORP Common equity shares | 1.2 | $97M | 23M | 4.21 | |
Biomarin Pharmaceutical Inc note 1.875% 4/2 | 1.0 | $81M | 23M | 3.55 | |
Medivation Inc note 2.625% 4/0 | 0.8 | $68M | 35M | 1.95 | |
Dyax | 0.8 | $62M | 6.2M | 10.12 | |
Acorda Therap note 1.75% 6/15 | 0.8 | $62M | 60M | 1.03 | |
Cerus Corporation (CERS) | 0.6 | $48M | 12M | 4.01 | |
Vanda Pharmaceuticals (VNDA) | 0.6 | $45M | 4.4M | 10.38 | |
Mirati Therapeutics | 0.5 | $42M | 2.4M | 17.51 | |
XenoPort | 0.5 | $37M | 6.8M | 5.38 | |
Slxp 1 1/2 03/15/19 | 0.5 | $36M | 15M | 2.42 | |
Derma Sciences | 0.4 | $30M | 3.5M | 8.33 | |
Repros Therapeutics | 0.3 | $28M | 2.8M | 9.90 | |
Gilead Sciences (GILD) | 0.3 | $27M | 256k | 106.45 | |
Acorda Therapeutics | 0.3 | $26M | 753k | 33.88 | |
Halozyme Therapeutics (HALO) | 0.3 | $25M | 2.8M | 9.10 | |
Versartis | 0.3 | $24M | 1.2M | 18.99 | |
Progenics Pharmaceuticals | 0.3 | $23M | 4.4M | 5.19 | |
Catalyst Pharmaceutical Partners (CPRX) | 0.3 | $22M | 6.7M | 3.32 | |
Tg Therapeutics (TGTX) | 0.3 | $22M | 2.1M | 10.67 | |
Heron Therapeutics (HRTX) | 0.3 | $22M | 2.6M | 8.33 | |
Arrowhead Research | 0.2 | $18M | 1.2M | 14.77 | |
Mallinckrodt Pub | 0.2 | $18M | 202k | 90.15 | |
Ambit Bioscience | 0.2 | $17M | 1.1M | 15.40 | |
Insmed (INSM) | 0.2 | $15M | 1.1M | 13.05 | |
Biomarin Pharmaceutical Inc note 0.750%10/1 | 0.2 | $13M | 13M | 1.06 | |
Omeros Corporation (OMER) | 0.1 | $10M | 809k | 12.72 | |
Tekmira Pharmaceuticals Corporation | 0.1 | $10M | 484k | 21.14 | |
Kythera Biopharmaceuticals I | 0.1 | $10M | 311k | 32.76 | |
Agios Pharmaceuticals (AGIO) | 0.1 | $10M | 170k | 61.35 | |
Sangamo Biosciences (SGMO) | 0.1 | $9.3M | 865k | 10.78 | |
Neurocrine Biosciences (NBIX) | 0.1 | $8.7M | 555k | 15.67 | |
Ultragenyx Pharmaceutical (RARE) | 0.1 | $8.5M | 150k | 56.60 | |
Threshold Pharmaceuticals | 0.1 | $7.8M | 2.2M | 3.61 | |
Aquinox Pharmaceuticals | 0.1 | $8.1M | 1.2M | 6.66 | |
Qlt | 0.1 | $6.9M | 1.5M | 4.52 | |
Proqr Thrapeutics N V shs euro (PRQR) | 0.1 | $6.9M | 400k | 17.19 | |
Osiris Therapeutics | 0.1 | $6.4M | 511k | 12.59 | |
Discovery Laboratories | 0.1 | $6.7M | 3.7M | 1.84 | |
Macrogenics (MGNX) | 0.1 | $6.5M | 312k | 20.90 | |
Aerie Pharmaceuticals | 0.1 | $6.2M | 299k | 20.69 | |
Epizyme | 0.1 | $5.8M | 214k | 27.11 | |
Bluebird Bio (BLUE) | 0.1 | $5.4M | 150k | 35.88 | |
Concert Pharmaceuticals I equity | 0.1 | $5.7M | 452k | 12.61 | |
Foamix Pharmaceuticals | 0.1 | $5.6M | 1.0M | 5.45 | |
Array BioPharma | 0.1 | $5.1M | 1.4M | 3.57 | |
Novavax | 0.1 | $5.1M | 1.2M | 4.17 | |
Ironwood Pharmaceuticals (IRWD) | 0.1 | $4.5M | 346k | 12.96 | |
Achillion Pharmaceuticals | 0.1 | $4.4M | 438k | 9.98 | |
Xencor (XNCR) | 0.1 | $5.0M | 542k | 9.31 | |
Ignyta | 0.1 | $4.6M | 571k | 8.06 | |
ISIS Pharmaceuticals | 0.1 | $3.7M | 96k | 38.83 | |
Idera Pharmaceuticals | 0.1 | $3.7M | 1.6M | 2.29 | |
Infinity Pharmaceuticals (INFIQ) | 0.1 | $4.2M | 312k | 13.42 | |
BioDelivery Sciences International | 0.1 | $3.6M | 210k | 17.09 | |
D Stemline Therapeutics | 0.1 | $4.2M | 339k | 12.46 | |
La Jolla Pharmaceuticl Com Par | 0.1 | $4.1M | 422k | 9.61 | |
Celladon | 0.1 | $3.9M | 375k | 10.46 | |
Celsus Therapeutics Plc sponsored adr ne | 0.1 | $4.1M | 674k | 6.10 | |
Amicus Therapeutics (FOLD) | 0.0 | $2.9M | 482k | 5.95 | |
Ligand Pharmaceuticals In (LGND) | 0.0 | $3.4M | 73k | 46.99 | |
Cytrx | 0.0 | $3.4M | 1.4M | 2.54 | |
Enanta Pharmaceuticals (ENTA) | 0.0 | $3.0M | 75k | 39.57 | |
Karyopharm Therapeutics (KPTI) | 0.0 | $3.3M | 94k | 34.94 | |
Lipocine | 0.0 | $3.1M | 500k | 6.11 | |
Zogenix | 0.0 | $2.7M | 2.4M | 1.15 | |
Synergy Pharmaceuticals | 0.0 | $2.7M | 973k | 2.78 | |
Biota Pharmaceuticals | 0.0 | $2.7M | 1.1M | 2.47 | |
Sage Therapeutics (SAGE) | 0.0 | $2.4M | 75k | 31.51 | |
Aurinia Pharmaceuticals (AUPH) | 0.0 | $2.3M | 728k | 3.21 | |
Affimed Therapeutics B V | 0.0 | $2.5M | 400k | 6.30 | |
Synta Pharmaceuticals | 0.0 | $1.5M | 500k | 3.01 | |
Salix Pharmaceuticals | 0.0 | $1.3M | 8.6k | 156.25 | |
OraSure Technologies (OSUR) | 0.0 | $1.7M | 235k | 7.22 | |
Mast Therapeutics | 0.0 | $1.7M | 3.0M | 0.56 | |
Receptos | 0.0 | $1.5M | 24k | 62.09 | |
Foundation Medicine | 0.0 | $1.5M | 78k | 18.96 | |
Ophthotech | 0.0 | $1.4M | 37k | 38.94 | |
Mediwound Ltd cmn | 0.0 | $1.4M | 225k | 6.30 | |
Alder Biopharmaceuticals | 0.0 | $1.9M | 153k | 12.68 | |
Loxo Oncology | 0.0 | $1.3M | 100k | 13.13 | |
Marinus Pharmaceuticals | 0.0 | $1.3M | 205k | 6.47 | |
Geron Corporation (GERN) | 0.0 | $805k | 403k | 2.00 | |
Rigel Pharmaceuticals (RIGL) | 0.0 | $935k | 482k | 1.94 | |
Alnylam Pharmaceuticals (ALNY) | 0.0 | $906k | 12k | 78.10 | |
ZIOPHARM Oncology | 0.0 | $646k | 245k | 2.64 | |
Tesaro | 0.0 | $840k | 31k | 26.91 | |
Acceleron Pharma | 0.0 | $870k | 29k | 30.25 | |
Achaogen | 0.0 | $896k | 100k | 8.96 | |
Cyclacel Pharmaceuticals Inc pfd conv ex 6% (CYCCP) | 0.0 | $103k | 13k | 7.77 | |
Chemocentryx | 0.0 | $225k | 50k | 4.50 | |
Five Prime Therapeutics | 0.0 | $233k | 20k | 11.75 | |
Uniqure Nv (QURE) | 0.0 | $284k | 31k | 9.26 |